Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidoglycan, also known as murein, is a unique and essential structural polymer found in the cell walls of almost all bacteria (Vollmer et al., 2008). It consists of glycan chains of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) residues linked by beta-(1,4)-glycosidic bonds, which are cross-linked by short peptide bridges (Schleifer & Kandler, 1972). This rigid framework provides structural integrity to the bacterial cell, maintaining its shape and protecting it against high internal osmotic pressure (StatPearls, 2023). Because peptidoglycan is absent in eukaryotic cells, it serves as a primary target for the innate immune system and antimicrobial agents (NCBI, 2022). Enzymes such as lysozyme specifically target and hydrolyze the beta-(1,4)-glycosidic bonds between NAM and NAG, leading to cell wall degradation and bacterial lysis (Phillips, 1966). In clinical medicine, while many antibiotics target the synthesis or cross-linking of peptidoglycan, the glycosidic bond itself is a critical site for host defense mechanisms and specialized therapeutic interventions, such as phage-derived endolysins, against bacterial infections (PubChem, 2024).
Enzymatic hydrolysis of the beta-(1,4)-glycosidic linkage between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) residues, leading to the degradation of the glycan backbone and subsequent bacterial cell lysis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan beta-(1,4)-glycosidic bond (PG glycosidic bond).